FDA recall D-0284-2022

Valgene Incorporated dba Cape Drugs · Class II · drug

Product

B-Complex, injection, 1 mL vials, Rx only, Cape Drugs 1384 Cape St. Claire Road Annapolis, MD 21409

Reason for recall

Lack of Processing Controls

Distribution

Maryland Only

Key facts

Status
Terminated
Initiation date
2021-12-03
Report date
2021-12-22
Termination date
2022-01-04
Voluntary/Mandated
Voluntary: Firm initiated
Location
Annapolis, MD, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0284-2022